Aquestive Therapeutics, Inc. (AQST)
4.08
-0.09
(-2.16%)
USD |
NASDAQ |
Apr 10, 16:00
4.075
0.00 (0.00%)
After-Hours: 20:00
Aquestive Therapeutics Total Assets (Quarterly) : 162.17M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Nektar Therapeutics | 280.41M |
| REGENXBIO, Inc. | 453.03M |
| Verastem, Inc. | 246.44M |
| Harrow, Inc. | 405.21M |
| ACADIA Pharmaceuticals, Inc. | 1.564B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 195.83M |
| Shareholders Equity (Quarterly) | -33.66M |
| Debt to Equity Ratio | -3.905 |
| Current Ratio | 3.135 |
| Net Debt Paydown Yield | -0.30% |